statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	535
SG - Singapore	170
IT - Italia	104
CN - Cina	83
VN - Vietnam	83
BR - Brasile	61
IE - Irlanda	41
SE - Svezia	40
HK - Hong Kong	38
BD - Bangladesh	27
DE - Germania	26
ZA - Sudafrica	20
FR - Francia	17
NL - Olanda	17
GB - Regno Unito	14
CA - Canada	13
IN - India	12
FI - Finlandia	9
JP - Giappone	6
MX - Messico	6
ES - Italia	5
TR - Turchia	5
AR - Argentina	4
AT - Austria	4
CI - Costa d'Avorio	4
CL - Cile	4
MY - Malesia	4
PA - Panama	4
PH - Filippine	4
PK - Pakistan	4
RU - Federazione Russa	4
TH - Thailandia	4
EC - Ecuador	3
EG - Egitto	3
ID - Indonesia	3
SA - Arabia Saudita	3
VE - Venezuela	3
JO - Giordania	2
LT - Lituania	2
MA - Marocco	2
PL - Polonia	2
BB - Barbados	1
BE - Belgio	1
BG - Bulgaria	1
BO - Bolivia	1
CR - Costa Rica	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
GE - Georgia	1
GR - Grecia	1
HR - Croazia	1
IQ - Iraq	1
IR - Iran	1
KR - Corea	1
MM - Myanmar	1
NP - Nepal	1
PE - Perù	1
PS - Palestinian Territory	1
PT - Portogallo	1
QA - Qatar	1
RO - Romania	1
SK - Slovacchia (Repubblica Slovacca)	1
TT - Trinidad e Tobago	1
UA - Ucraina	1
UZ - Uzbekistan	1
Totale	1.419

Nome	#
Chest x-ray or CT for COVID-19 pneumonia? Comparative study in a simulated triage setting	225
COVID-19 in Children: Update on Diagnosis and Management	151
Structural changes in lung morphology detected by MRI after modulating therapy with elexacaftor/tezacaftor/ivacaftor in adolescent and adult patients with cystic fibrosis	150
Renal artery embolization of non-functioning graft: an effective treatment for graft intolerance syndrome	133
Clinical Impact of Aspergillus fumigatus in Children with Cystic Fibrosis	132
Validation by CT scan of quadriceps muscle thickness measurement by ultrasound in acute kidney injury	124
The impact of muscle mass and myosteatosis on mortality in critically ill patients with Sars-Cov2-related pneumonia	123
Detection and Classification of Bronchiectasis through Convolutional Neural Networks	108
Imaging in non-cystic fibrosis bronchiectasis and current limitations	108
The Trajectories of Neuromuscular Aging (TRAJECTOR-AGE Clinical Trial): Study Rationale and Methodological Protocol	86
Effect of elexacaftor-tezacaftor-ivacaftor modulator on lung structure in cystic fibrosis	73
Effect of elexacaftor-tezacaftor-ivacaftor modulator on lung structure in cystic fibrosis	22
Totale	1.435

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	4	0	0	0	0	0	0	0	0	0	0	0	4
2021/2022	47	2	1	6	2	2	3	8	4	2	0	1	16
2022/2023	182	18	23	13	22	18	16	1	13	48	1	4	5
2023/2024	90	8	7	3	4	1	20	17	4	6	3	9	8
2024/2025	268	8	11	29	22	25	23	16	12	30	23	29	40
2025/2026	808	65	44	109	70	102	59	68	35	111	78	43	24
Totale													1.435